During the EuroPCR 2017, I met 45 PI of the EASTBOURNE Registry to talk about the end point and the trend of the Study. There were PI from all around the world (Spain, China, Italy, Japan, England, India, etc.).
The EASTBOURNE Registry, thE All-comers Sirolimus-coaTed BallOon eURopeaN rEgistry, has been created to observe and evaluate the performance of a Sirolimus-
eluting Drug-Coated Balloon (SCB) for the treatment of any type of coronary lesions, including native vessel disease and in-stent restenosis.
The Registry has the following characteristics:
•Prospective, multicenter, spontaneous clinical registry
•real world, all comers patients
Here’s the presentation of the meeting1 EASTBOURNE Investigator Meeting